Metabolic disorders, linked to alterations in glucose and lipid metabolism, are involved in numerous diseases, including diabetes, obesity, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) and MASH (Metabolic Dysfunction-Associated Steatohepatitis). Their increasing prevalence makes understanding these conditions a major focus of biomedical research.
To better understand the biological mechanisms underlying these diseases and identify new therapeutic opportunities, Cayman provides a wide range of research tools dedicated to the study of insulin resistance, abdominal obesity, dyslipidaemia and hypertension. Distributed in France by Bertin Bioreagent, these solutions enable researchers to explore the key pathways involved in the development and progression of metabolic disorders.
To support your research projects, the Metabolic Disorder guide brings together a selection of solutions dedicated to studying the major mechanisms involved in metabolic diseases.
